The retooled SEC enforcement program is filing more cases and securing judgments for more dollars than in prior years according to the statistics (here). A significant component of those statistics is investment fund fraud actions. Once considered difficult to discover…

FDA chemist Cheng Yi Liang was named as a defendant along with his son Andrew Liang in a criminal insider trading complaint. U.S. v. Liang (D. Md. Filed March 29, 2011). The SEC filed a parallel action against the chemist.…